FDA panel endorses Johnson & Johnson COVID-19 vaccine booster with 2-month gap for ages 18 and up
October 16 2021, 08:00
A Food and Drug Administration (FDA) advisory committee on Friday endorsed an emergency authorization for the Johnson & Johnson COVID-19 vaccine booster when administered at least two months after the initial dose among people ages 18 years and older.
A Food and Drug Administration (FDA) advisory committee on Friday endorsed an emergency authorization for the Johnson & Johnson COVID-19 vaccine booster when administered at least two months after the initial dose among people ages 18 years and older.
Source:
FOX News